National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 8/28/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Jeremy S. Abramson, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Constellation, Inc.;
Gilead;
Seattle Genetics;
Pharmacyclics

Jannsen Pharmaceutica Products, LP;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Millennium Pharmaceuticals, Inc.;
Gilead;
Spectrum

None

None

8/23/2014

Ranjana H. Advani, MD

Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Agensys;
Allos Therapeutics;
Idera Pharmaceuticals;
Seattle Genetics;
Pharmacyclics

Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Clarient;
Seattle Genetics

None

None

5/2/2014

C. Babis Andreadis, MD, MSCE

GlaxoSmithKline

Millennium Pharmaceuticals, Inc.;
Spectrum;
Pharmacyclics

Roche Laboratories, Inc.

None

5/28/2014

Nancy Bartlett, MD

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
MedImmune Inc.;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Seattle Genetics;
Pfizer Inc.;
Pharmacyclics

Seattle Genetics

None

None

4/14/2014

John C. Byrd, MD

None

Genentech, Inc.;
Pharmacyclics

None

None

6/4/2014

Myron S. Czuczman, MD

Celgene Corporation;
Onyx Pharmaceuticals, Inc.;
Gilead

Boehringer Ingelheim GmbH;
Celgene Corporation;
Algeta;
Mundipharma;
Teva

None

None

5/22/2014

Mary Dwyer, MS

None

None

None

None

3/7/2014

Luis E. Fayad, MD

Centocor, Inc.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.;
sanofi-aventis U.S.;
Wyeth Pharmaceuticals

None

None

None

9/18/2013

Richard I. Fisher, MD

None

Johnson & Johnson;
Coherus Bioscience;
Giliad

None

None

5/5/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/4/2014

Martha J. Glenn, MD

Amgen Inc.;
Institutional DSMC;
sanofi-aventis U.S.

None

None

None

6/2/2014

Leo I. Gordon, MD

None

None

None

None

6/3/2014

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Nancy Lee Harris, MD

Pharmacyclics

None

None

None

5/19/2014

Richard T. Hoppe, MD

None

Clarient

None

None

5/19/2014

Steven M. Horwitz, MD

Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
;
Infinity;
Kiowa-Kirin;
Seattle Genetics;
spectrum

Amgen Inc.;
Bristol-Myers Squibb Company;
Celgene Corporation;
Millennium Pharmaceuticals, Inc.;
Actelion;
Kiowa Hakka Kirin;
Spectrum

None

None

6/23/2014

Christopher R. Kelsey, MD

Varian Medical Systems, Inc.

None

None

None

6/2/2014

Youn H. Kim, MD

Eisai Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
KHK;
Seattle Genetics;
SHAPE

Celgene Corporation;
Actelion;
Galderma

None

Eisai Inc.;
Millennium Pharmaceuticals, Inc.

6/5/2014

Susan Krivacic, MPAff

None

None

None

None

5/6/2014

Ann S. LaCasce, MD

None

GlaxoSmithKline

None

None

5/23/2014

Joan S. McClure, MS

None

None

None

None

6/20/2014

Auayporn Nademanee, MD

Celgene;
Seattle Genetics Co.

None

None

None

5/22/2014

Elise A. Olsen, MD

Eisai Inc.

Actelion

None

None

7/15/2014

Pierluigi Porcu, MD

Infinity;
OncoMed;
Seattle Genetics

Celgene Corporation;
Actelion

None

None

6/3/2014

Oliver Press, MD, PhD

Genentech, Inc.;
Roche Laboratories, Inc.

Algeta;
BIND Biosciences

Emergent Biosolutions

None

4/7/2014

Rachel Rabinovitch, MD

RTOG Data Safety and Monitoring Board

None

None

Accuray Incorporated

4/22/2014

Nishitha Reddy, MD

Celgene Corporation

Celgene Corporation

None

None

11/21/2013

Erin Reid, MD

Bristol-Myers Squibb Company;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Abbvie Pharmaceuticals;
AIDS Malignancy Consortium;
CALGB/CTSU;
Isis;
Pharmacyclics;
Takeda Pharmaceuticals North America, Inc.

Seattle Genetics

None

None

6/17/2014

Ayman A. Saad, MD

None

IMS Consulting Group

None

None

6/26/2014

Lubomir Sokol, MD, PhD

None

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Jannsen Pharmaceutica Products, LP;
Onyx Pharmaceuticals, Inc.;
Spectrum

None

None

5/2/2014

Hema Sundar, PhD

None

None

None

None

1/13/2014

Lode J. Swinnen, MB, ChB

Abbott Laboratories

None

None

None

11/6/2013

Sarika Trikha

None

None

None

None

5/19/2014

Christina Tsien, MD

None

None

None

None

5/27/2014

Julie M. Vose, MD, MBA

Bristol-Myers Squibb Company;
Celgene Corporation;
Genentech, Inc.;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Onyx Pharmaceuticals, Inc.;
Incyte;
US Biotest;
US Biotest, Inc.;
Pharmacyclics;
sanofi-aventis U.S.

None

None

None

6/3/2014

William G. Wierda, MD, PhD

Abbott Laboratories;
GlaxoSmithKline

Celgene Corporation;
Genentech, Inc.;
Roche Laboratories, Inc.

None

None

6/5/2014

Joachim Yahalom, MD

None

None

None

None

8/18/2014

Nadeem Zafar, MD

None

None

None

None

6/3/2014

Andrew D. Zelenetz, MD, PhD

Abbott Laboratories;
Boehringer Ingelheim GmbH;
Celgene Corporation;
Genentech, Inc.;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Novartis Pharmaceuticals Corporation;
Onyx Pharmaceuticals, Inc.;
Constellation Pharmaceuticals;
Curis;
Gilead;
Infinity;
Seattle Genetics

Amgen Inc.;
Celgene Corporation;
Genentech, Inc.;
Bullet Bio Technology;
Cancer Genetics;
Dr. Reddy`s Laboratories;
Emergent Biosolutions;
Foundation Medicine;
Gilead;
Hospira;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

6/16/2014